Company / Return on Assets (ROA)
Relay Therapeutics, Inc. Return on Assets (ROA) History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-44.5%
FY2025
5-year range
-44.5% / -4.8%
FY2021-FY2025
Trend
-14.8%
vs FY2024
Sector context
#169 of 213
Health Care
What the data says
Relay Therapeutics, Inc.'s return on assets (roa) of -44.5% is lower than 79% of companies in the Health Care sector (FY2025). Return on Assets (ROA) has fluctuated over the past 7 years, ranging from -44.5% in FY2025 to -4.8% in FY2022.
Based on SEC 10-K filings.
-44.5% in FY2025 with a 5-year CAGR of -35.1%.
Declined from -40.5% to -44.5% over the past 2 years.
Health Care sector context is included.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -39.7pp
- 5-Year Change
- -35.1pp
- 10-Year Change
- -
Sector benchmark
-84.1% below sector average
Key checks
Key Insights
- In FY2025, return on assets (roa) decreased 14.8% year-over-year.
- Currently 20.3pp below the Health Care sector average.
- Peak return on assets (roa) was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score 0.79 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -44.5% | -14.8% |
| FY2024 | -38.8% | +4.3% |
| FY2023 | -40.5% | -749.5% |
| FY2022 | -4.8% | +36.1% |
| FY2021 | -7.5% | +20.7% |
| FY2020 | -9.4% | +50.8% |
| FY2019 | -19.2% | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026